Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
about
Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prThe cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis.All-trans- and 9-cis-retinoic acids activate the human cyclooxynase-2 gene: a role for DR1 as RARE or RXRE.The use of Cox-2 and PPARγ signaling in anti-cancer therapies.The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system
P2860
Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@en
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@nl
type
label
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@en
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@nl
prefLabel
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@en
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@nl
P2093
P2860
P50
P356
P1476
Nimesulide, a preferential cyc ...... dence for receptor antagonism.
@en
P2093
John A Di Battista
Qing Wen He
Tanja Kalajdzic
P2860
P304
P356
10.1002/ART.10055
P577
2002-02-01T00:00:00Z